| 000 | 01427nam a2200385 i 4500 | ||
|---|---|---|---|
| 005 | 20250919212006.0 | ||
| 008 | 171128s2017 xx a 000 0 eng | ||
| 020 |
_a9781536105049 (v. 1) _cRM933.00 |
||
| 020 | _a9781536105056 (v. 2) | ||
| 039 | 9 |
_a201712131306 _bfadza _y11-28-2017 _zruzini |
|
| 040 |
_aDLC _beng _erda _cDLC _dUKM _erda |
||
| 090 | _aQU143.A244 2017 9 | ||
| 090 |
_aQU143 _b.A244 2017 9 |
||
| 245 | 0 | 0 |
_aAdvances in studies on enzyme inhibitors as drugs _cSatya P. Gupta, editor. |
| 264 | 1 |
_aNew York : _bNova Biomedical, _c2017. |
|
| 264 | 4 | _c©2017. | |
| 300 |
_avolumes : _billustrations ; _c26 cm. |
||
| 336 |
_atext _2rdacontent |
||
| 337 |
_aunmediated _2rdamedia |
||
| 338 |
_avolume _2rdacarrier |
||
| 490 | 1 | _aPharmacology-research, safety testing, and regulation | |
| 504 | _aIncludes bibliographical references and index. | ||
| 505 | 0 | _aVolume 1. Anticancer and antiviral drugs -- volume 2. Miscellaneous drugs -- | |
| 650 | 2 | _aEnzyme inhibitors. | |
| 700 | 1 |
_aGupta, Satya P., _eeditor. |
|
| 830 | 0 | _aPharmacology-research, safety testing, and regulation | |
| 907 |
_a.b16533008 _b2019-11-12 _c2019-11-12 |
||
| 942 |
_c01 _n0 _kQU143.A244 2017 9 |
||
| 914 | _avtls003628198 | ||
| 990 | _amfh | ||
| 991 | _aFakulti Farmasi, KKL | ||
| 998 |
_ad _b2017-02-11 _cm _da _feng _gxx _y0 _z.b16533008 |
||
| 999 |
_c689776 _d689776 |
||